Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration
Related Experiment Video
Updated: Aug 11, 2026

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
Published on: July 14, 2016
Bert Gold1, Joanna E Merriam, Jana Zernant
1Laboratory of Genomic Diversity, National Cancer Institute, Frederick, Maryland 21702, USA.
Insights
Genetic variations in factor B (BF) and complement component 2 (C2) genes are linked to age-related macular degeneration (AMD) risk. Specific BF and C2 haplotypes significantly reduce AMD risk, improving prediction when combined with CFH variants.
Area of Science:
- Genetics
- Ophthalmology
- Immunology
Background:
- Age-related macular degeneration (AMD) is a leading cause of irreversible blindness globally.
- Complement factor H (CFH) gene variants are known risk factors for AMD.
- The alternative complement pathway plays a crucial role in AMD pathogenesis.
Purpose of the Study:
- To investigate the association of genetic variations in factor B (BF) and complement component 2 (C2) genes with AMD risk.
- To identify specific haplotypes within BF and C2 that confer risk or protection against AMD.
- To assess the combined predictive power of CFH, BF, and C2 variants for AMD clinical outcomes.
Main Methods:
- Screening of BF and C2 genes for genetic variation in two independent cohorts.
- Analysis of approximately 900 individuals with AMD and 400 matched controls.
- Haplotype analyses to identify risk and protective genetic variants.
Main Results:
- A common risk haplotype (H1) and two protective haplotypes were identified in BF and C2.
- Specific BF (L9H) and C2 (E318D) variants (haplotype H10) significantly reduced AMD risk (OR=0.45).
- A C2 intron 10 variant combined with BF R32Q variant (haplotype H7) also significantly reduced AMD risk (OR=0.36).
Conclusions:
- Genetic variations in BF and C2 are associated with AMD risk, expanding the known genetic factors.
- Combined analysis of CFH, BF, and C2 variants can predict AMD clinical outcomes with substantial accuracy.
- These findings refine the understanding of the complement system's role in AMD pathogenesis and genetic risk.
Abstract:
Age-related macular degeneration (AMD) is the most common form of irreversible blindness in developed countries. Variants in the factor H gene (CFH, also known as HF1), which encodes a major inhibitor of the alternative complement pathway, are associated with the risk for developing AMD. Here we test the hypothesis that variation in genes encoding other regulatory proteins of the same pathway is associated with AMD. We screened factor B (BF) and complement component 2 (C2) genes, located in the major histocompatibility complex class III region, for genetic variation in two independent cohorts comprising approximately 900 individuals with AMD and approximately 400 matched controls. Haplotype analyses identify a statistically significant common risk haplotype (H1) and two protective haplotypes. The L9H variant of BF and the E318D variant of C2 (H10), as well as a variant in intron 10 of C2 and the R32Q variant of BF (H7), confer a significantly reduced risk of AMD (odds ratio = 0.45 and 0.36, respectively). Combined analysis of the C2 and BF haplotypes and CFH variants shows that variation in the two loci can predict the clinical outcome in 74% of the affected individuals and 56% of the controls. These data expand and refine our understanding of the genetic risk for AMD.
Related Concept Videos
Genetic Lingo
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...
Complementation Tests
Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Photoreceptors and Visual Pathways

